Ritonavir-boosted ARV linked to adrenal dysfunction in babies

被引:0
|
作者
机构
关键词
Zidovudine; Ritonavir; Congenital Adrenal Hyperplasia; Lopinavir; 17OHP Level;
D O I
10.2165/00128415-201113600-00001
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [31] Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports
    Gallagher, David P.
    Kieran, Jennifer
    Sheehan, Gerard
    Lambert, John
    Mahon, Niall
    Mallon, Patrick W. G.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (03) : E36 - E38
  • [32] The use of dual maraviroc/ritonavir-boosted darunavir combination in clinical practice
    Vishwanath, V.
    Singh, G. K. J.
    Dub, S.
    Bower, M.
    Nelson, M.
    HIV MEDICINE, 2013, 14 : 59 - 59
  • [33] Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir
    Song, Ivy
    Borland, Julie
    Min, Sherene
    Lou, Yu
    Chen, Shuguang
    Patel, Parul
    Wajima, Toshihiro
    Piscitelli, Stephen C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) : 3517 - 3521
  • [34] Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
    Violari, Avy
    Lindsey, Jane C.
    Hughes, Michael D.
    Mujuru, Hilda A.
    Barlow-Mosha, Linda
    Kamthunzi, Portia
    Chi, Benjamin H.
    Cotton, Mark F.
    Moultrie, Harry
    Khadse, Sandhya
    Schimana, Werner
    Bobat, Raziya
    Purdue, Lynette
    Eshleman, Susan H.
    Abrams, Elaine J.
    Millar, Linda
    Petzold, Elizabeth
    Mofenson, Lynne M.
    Jean-Philippe, Patrick
    Palumbo, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (25): : 2380 - 2389
  • [35] Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
    Kaeser, Benoite
    Zandt, Hagen
    Bour, Fabrice
    Zwanziger, Elke
    Schmitt, Christophe
    Zhang, Xiaoping
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 609 - 614
  • [36] Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine
    Ramanathan, Srinivasan
    Kakuda, Thomas N.
    Mack, Rebecca
    West, Steve
    Kearney, Brian P.
    ANTIVIRAL THERAPY, 2008, 13 (08) : 1011 - 1017
  • [37] Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?
    Hamada, Yohei
    Nishijima, Takeshi
    Komatsu, Hirokazu
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    PLOS ONE, 2013, 8 (07):
  • [38] Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin
    Gausi, Kamunkhwala
    Mugerwa, Henry
    Siccardi, Marco
    Montanha, Maiara Camotti
    Lamorde, Mohammed
    Wiesner, Lubbe
    D'Avolio, Antonio
    Mcilleron, Helen
    Wilkins, Edmund
    De Nicolo, Amedeo
    Maartens, Gary
    Khoo, Saye
    Kityo, Cissy
    Denti, Paolo
    Waitt, Catriona
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1246 - 1255
  • [39] Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use
    Goicoechea, Miguel
    Best, Brookie
    Capparelli, Edmund
    Caperna, Joseph
    Ballard, Craig
    Haubrich, Richard
    AIDS, 2006, 20 (16) : 2127 - 2128